Safe and Efficient Process for industrial synthesis of DRINABANT®
Anthony Bigot

Download CV


The development of a chemical synthesis that will ultimately be used for the commercial production of a drug is a long process, with a lot of hurdles and regulatory constraints that may not be familiar to most of the research chemistry community. In this talk, I will use the synthesis of Drinabant as an example in order to show how to tackle the different constraints (environmental, hygyène, safety, regulatory, etc) in order to propose a synthetic route that could be used for commercial production




Back to Speakers